Sino Biopharmaceutical (Sino Biopharmaceutical) Receivables Turnover : 2.01 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Sino Biopharmaceutical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sino Biopharmaceutical's Revenue for the six months ended in Dec. 2023 was $1,530 Mil. Sino Biopharmaceutical's average Accounts Receivable for the six months ended in Dec. 2023 was $761 Mil. Hence, Sino Biopharmaceutical's Receivables Turnover for the six months ended in Dec. 2023 was 2.01.

Sino Biopharmaceutical Receivables Turnover Historical Data

The historical data trend for Sino Biopharmaceutical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Receivables Turnover Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

9.61

11.34

9.83

7.12

6.90

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial															3.02	3.62	2.44	2.79	2.01

Competitive Comparison of Sino Biopharmaceutical's Receivables Turnover

For the Biotechnology subindustry, Sino Biopharmaceutical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Receivables Turnover falls into.

Sino Biopharmaceutical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Sino Biopharmaceutical's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	3669.282	/ (	(533.9	+	529.035)	/	2 )
=	3669.282	/	531.4675
=	6.90

Sino Biopharmaceutical's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	1529.701	/ (	(992.679	+	529.035)	/	2 )
=	1529.701	/	760.857
=	2.01

Sino Biopharmaceutical (OTCPK:SBHMY) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Sino Biopharmaceutical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBHMY) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

SBMFF:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.